Vision 2020: Takeda and the Vaccine Business Harvard Case Solution & Analysis

Colour cases ought to be printed in color to optimize their effectiveness. In the year 2014, Yasuchika Hasegawa was advocating the transfer of Takeda from a Japan based pharmaceutical company with an international footprint into a global business with a Japanese based tradition. A 33-year veteran of Takeda, Hasegawa-san was made president of Takeda in 2003 and chief executive in 2009. In the midst of implementing its new Vision 2020 plan, a tactical plan for the international corporation that is evolving, which included developing a global vaccine business, Takeda was by 2013.

Vision 2020 Takeda and the Vaccine Business Case Study Solution

PUBLICATION DATE: March 12, 2014 PRODUCT #: 514084-HCC-ENG

This is just an excerpt. This case is about SALES & MARKETING

Share This

SALE SALE

Save Up To

30%

IN ONLINE CASE STUDY

FOR FREE CASES AND PROJECTS INCLUDING EXCITING DEALS PLEASE REGISTER YOURSELF !!

Register now and save up to 30%.